Silva Ana Carina, Delgado Inês, Sousa Marcos F Q, Carrondo Manuel J T, Alves Paula M
ITQB-UNL/IBET, Apartado 12, Oeiras, Portugal.
Vaccine. 2008 Jun 19;26(26):3305-11. doi: 10.1016/j.vaccine.2008.03.077. Epub 2008 Apr 18.
Peste des Petits ruminants (PPR) is considered as one of the major constraints to the productivity of small ruminants in Africa and Asian countries. Currently PPR control is done by vaccination with an attenuated PPR strain (Nigeria 75/1) produced in monolayers of Vero cells grown in roller bottles or static flasks. This work focuses on the production of a PPR vaccine strain using stirred conditions as an advanced option for process scale-up. Non-porous microcarriers (Cytodex-1) were used to support Vero cell growth in suspension cultures. The use of Ex-Cell medium could improve cell specific productivities obtained with standard serum containing medium, independently of the type of system used, i.e. static as well as suspension stirred cultures. As an alternative, several cell lines adapted to grow as single cells in suspension (CHO-K1, BHK-21A and 293) and another anchorage-dependent (MRC-5) were evaluated in their capacity to produce a PPR vaccine. BHK-21A and 293 cells grown as single-cell suspension in serum free medium were both suited to produce PPR vaccine with productivities similar to Vero cells, namely 10(6)TCID(50)/mL. However, for the 293 cells, these results were only obtained 2-3 days later. CHO-K1 and MRC-5 cells have shown not to be suitable to adequately produce this virus. These results provide further insights into the feasibility of applying microcarrier cell culture technology to produce PPR vaccine in Vero cells as well as in the alternative use of single-cell suspension cultures of BHK-21A, significantly simplifying the existing production process.
小反刍兽疫(PPR)被认为是非洲和亚洲国家小反刍动物生产力的主要制约因素之一。目前,PPR的防控是通过接种在滚瓶或静止培养瓶中生长的Vero细胞单层上生产的减毒PPR毒株(尼日利亚75/1)来实现的。这项工作聚焦于使用搅拌条件生产PPR疫苗毒株,作为工艺放大的一种先进选择。使用无孔微载体(Cytodex-1)来支持Vero细胞在悬浮培养中的生长。无论使用何种系统,即静态培养还是悬浮搅拌培养,使用Ex-Cell培养基都可以提高在含标准血清培养基中获得的细胞比生产力。作为替代方案,评估了几种适应在悬浮状态下以单细胞形式生长的细胞系(CHO-K1、BHK-21A和293)以及另一种贴壁依赖性细胞系(MRC-5)生产PPR疫苗的能力。在无血清培养基中以单细胞悬浮形式生长的BHK-21A和293细胞都适合生产PPR疫苗,其生产力与Vero细胞相似,即10(6)TCID(50)/mL。然而,对于293细胞,这些结果仅在2 - 3天后获得。CHO-K1和MRC-5细胞已证明不适合充分生产这种病毒。这些结果为将微载体细胞培养技术应用于在Vero细胞中生产PPR疫苗以及替代使用BHK-21A单细胞悬浮培养的可行性提供了进一步的见解,显著简化了现有的生产工艺。